Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2025-12-25 @ 2:49 AM
NCT ID: NCT03731533
Eligibility Criteria: Inclusion Criteria: * Established diagnosis of type 2 diabetes (T2DM) * Between the ages of 18 and 65 years-old * Own and willing to use a smart phone or computer, and have daily internet access * Have an email account * Have access to resources (finances and transportation) that allow for regular acquisition (at least once weekly) of groceries, including produce * Access to resources that allow for food preparation at home (refrigeration, basic kitchen appliances and supplies) * Willingness to attempt changes in food preparation and consumption, and physical activity. -Scoring at least a 7/10 in both readiness for change and confidence of success; 1= not ready / no confidence; 10 = extremely ready / extremely confident of success - Exclusion Criteria: * Dementia * Advanced renal disease (stage 4 or 5) with or without hemodialysis * Congestive Heart Failure * Taking warfarin * Pregnancy or plans for pregnancy * Current smoker of tobacco cigarettes * Adults who have a physical limitation to prepare their own food or incorporate movement into their lifestyle (based on questionnaire answer) * Brittle diabetes and/or history of hospitalization for high or low blood sugar * Difficult-to-control hypertension and / or on 4 or more medications for high blood pressure. * Does not speak or understand English * Inability to use email or the Internet
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT03731533
Study Brief:
Protocol Section: NCT03731533